- Pagina principale
- Analisi delle app
- ocScribe
- ocScribe Vs. Orthotica Pocket 3D
ocScribe vs. Orthotica Pocket 3D Utilizzo e statistiche
AI-Driven Medical Transcription Software
Tailored to clinicians to eliminate the burden of note-taking. By freeing up valuable time in your schedule, ocScribe empowers medical professionals to focus on providing exceptional patient care.
- converts conversations into SOAP notes
- End-to-end encryption
- HIPAA compliant
- Designed for accessibility
- Built to scale and learn
Wellbeing for Doctors,
Wellness for Patients.
- App Store di Apple
- Gratis
- Settore Medico
Classifica degli store
- -
Pocket3D by Orthotica Labs™
Overview
Orthotica’s Pocket 3D is a powerful digital scanning tool designed specifically for lower extremity practitioners that leverages FaceID forward facing cameras on iPad Pro and select iPhone models. Developed by Orthotica Labs™, this companion app integrates into the Orthotica3D V3 ordering platform, giving you even more options for 3D scanning.
Key Features
1. 3D Scanning: The Pocket3D companion app leverages the forward facing FaceID camera, transforming an ordinary iPad Pro or iPhone X or newer into a high-precision 3D scanner. Practitioners can capture accurate foot and lower extremity scans effortlessly.
Orthotica Labs™ is committed to supporting clinicians in their patient care journey. By prioritizing quality, reliability, and efficiency, we empower practitioners to provide exceptional orthotic services.
- App Store di Apple
- Gratis
- Settore Medico
Classifica degli store
- -
ocScribeRanking a confronto con Orthotica Pocket 3D
Confronta la tendenza di classifica ocScribe nei ultimi 28 giorni rispetto a Orthotica Pocket 3D
Rank
Nessun dato disponibile
Classifica ocScribe vs. Orthotica Pocket 3D per paese a confronto
Confronta la tendenza di classifica ocScribe nei ultimi 28 giorni rispetto a Orthotica Pocket 3D
Nessun dato da visualizzare
Fai confronti con qualsiasi sito con la nostra prova gratuita
ocScribe VS.
Orthotica Pocket 3D
17icembre d, 2024